Delivery Order FA807514D0003-0004

Award Date 5/20/15
Potential Completion Date 9/30/16
Potential Value $12M
Funding Federal Agency
Air Force Materiel Command
Contracting Federal Agency
Defense Contract Management Agency
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Columbus, OH 43201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded under the Homeland Defense and Security Technical Area Tasks (HD TATs) IDIQ contract, issued by the U.S. Air Force Materiel Command. The $5,256,015.00 contract was awarded to Battelle Memorial Institute, a non-profit research and development organization, to provide Ebola diagnostics, field analytics, and sequencing support for the Joint Product Manager Medical Countermeasure Systems. Luminex Corporation, a manufacturer of biological testing technologies, was...
Battelle Memorial Institute was awarded a $7,299,201 cost-plus-award-fee delivery order contract by the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases. The contract calls for Battelle to conduct evaluation of filovirus vaccines in general use prophylaxis immunogenicity and Ebola virus challenge studies to identify potential correlates of protection, with a period of performance through December 2023. Envigo...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization. The $5,638,781.12 cost-plus-award-fee contract supports the evaluation of Ebola virus and other filovirus vaccines in a novel ferret model. This work is part of the NIAID's broader efforts to develop medical countermeasures against...
This is a $4,626,893.20 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute. The contract is for the evaluation of filovirus vaccines in general use prophylaxis (GUP) immunogenicity and filovirus challenge studies. Key subcontractors include Integrated Biotherapeutics, LLC, a small disadvantaged business, which provided services related to filovirus...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research and development organization. The $2,221,940.37 delivery order contract is for preparedness and testing of NIAID priority vaccines in general safety and toxicology studies. It does not have a set-aside designation. Battelle has subcontracted portions of the work to Envigo Global...
This federal contract award to Battelle Memorial Institute, a nonprofit research and development organization, supports the development of the CAD3-EBO-S (Sudan virus) candidate vaccine. The $11,947,532 cost-plus-fixed-fee contract was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) and does not have a set-aside designation. As part of this award, Battelle is collaborating with Texas Biomedical Research Institute and Integrated Biotherapeutics, LLC to conduct...
This is a task order awarded under the Homeland Defense and Security Technical Area Tasks (HD TATs) contract, a multiple-award indefinite delivery/indefinite quantity (IDIQ) contract administered by the Joint Program Executive Office for Chemical and Biological Defense. The $44,826,566.36 cost-plus-fixed-fee task order was awarded to Battelle Memorial Institute to provide research, development, test, and evaluation, as well as strategic initiatives, related to cross-commodity advanced threats....
This is a delivery order awarded to Battelle Memorial Institute, a nonprofit research and development organization, by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency. The award, which does not have a set-aside designation, is part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract called BATTELLE IDIQ. The contract has a ceiling value of $2,492,686.00 and a performance period ending on September 25, 2029. As a prime contractor, Battelle...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.6 million cost-plus-fixed-fee delivery order contract to Battelle Memorial Institute. The prime contractor will provide research and development services for biomedical and applied exploratory development related to evaluation and testing of vaccines and other biologics for infectious diseases. Two subcontractors, the University of Texas Medical Branch at...
This is a $265,960.21 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Battelle Memorial Institute, a nonprofit research and development organization. The contract is for evaluation and testing services for vaccines and other biologics for infectious diseases, with an ultimate completion date of April 30, 2018. The contract type is cost-plus-fixed-fee, and there is no set-aside...

This is a delivery order issued against the Homeland Defense and Security Technical Area Tasks (HD TATs) indefinite-delivery indefinite-quantity (IDIQ) contract, which is held by the U.S. Air Force Materiel Command. The $12,284,540.00 contract was awarded to Battelle Memorial Institute, a non-profit research and development organization, to support the Joint Vaccine Acquisitions Program's advanced filovirus vaccine development and continued medical countermeasures research. The contract involves vaccine R&D, including a clinical Phase 1 trial and good manufacturing practice (GMP) production of rVSVN4CT1 vectored Ebola-Sudan and Marburg-Angola vaccines. Battelle is working with subcontractors Profectus Biosciences, a small business specializing in vaccine development, and Mimotopes, a manufacturer, to execute the technical requirements. This award does not utilize any set-aside designations.

Generated 4/1/25, 8:03 PM